[Click eStock] "Cosmax, Achievable Sales Target... Buy Recommendation"

Kiwoom Securities stated on the 13th that Cosmax is fully capable of achieving its sales target for this year and recommended buying if volatility increases.

Sojeong Cho, a researcher at Kiwoom Securities, said, "Cosmax is a company that can benefit both inside and outside China, so we raised our earnings estimates." She also raised Cosmax's target stock price to 220,000 KRW.

Cosmax set its annual sales growth targets for this year at 20% domestically, 10% in China, 25% in Indonesia, and +10% in the United States. Domestically, the lifting of the Chinese ban on Korean content (Hanhanryeong) and strong exports from indie clients are expected to drive performance, while overseas, China's stimulus measures and the introduction of mandatory halal certification in Indonesia are expected to boost results.

Regarding this, researcher Cho judged, "We expect the targets to be fully achieved, and the Chinese subsidiary may even exceed them depending on local consumer sentiment." About the U.S., she said, "Even if the sales growth rate is achieved, we should be conservative about achieving profitability," but added, "The continued deficit of the U.S. subsidiary has been recognized for a long time, so there is no major concern."